Jeff Dykan has served on ReWalk’s board of directors since 2006 and its chairman since 2009. Mr. Dykan has been director of the general partner of Vitalife’s joint general partner since 2002 and of its successor fund SCP Vitalife, an Israeli venture capital fund, since 2007. Prior to joining Vitalife, Mr. Dykan was the Chairman and Chief Executive Officer of BitBand Inc. from 2001 to 2002. Mr. Dykan is a member of the American Institute of CPAs and holds a B.Sc. in Auditing and Management and an MBA in Computer Applications from New York University.
CEO und Director
Larry Jasinskihas been Chief Executive Officer and Board Member of ReWalk since February 2012. From 2005 to 2012, Mr. Jasinski was President and Chief Executive Officer of Soteira, Inc., which was acquired by Globus Medical in 2012 and is involved in the development and marketing of products used to treat individuals with vertebral compression fractures. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., which was acquired by Alphatec in 2005 and has developed state-of-the-art treatments for degenerative disc treatments. From 1985 to 2001, Mr. Jasinski held various sales, research, development, and general management roles with Boston Scientific Corporation. Mr. Jasinski holds a B.Sc.
Yasushi Ichiki has been on the board of ReWalk since 2014. Mr. Ichiki has been the manager of the Corporate Planning Group, the corporate planning division of Yaskawa Electric Corporation, since May 2014. Before that, from February 2010 to April 2014, he was General Manager of Corporate Planning, Robotics Division of Yaskawa Europe GmbH. Mr. Ichiki holds a BA from Yamaguchi University, Japan.
Wayne B. Weisman
Wayne B. Weismanhas been on the board of ReWalk since 2009. Mr. Weisman has been Director of the general partner of the common general partner of SCP Vitalife since 2007. He was also an executive member of SCP Vitalife Management Company, LLC, which provides contracted management services to the ordinary general partner of SCP Vitalife. Mr. Weisman is the CEO of Recro Pharma, Inc. (Nasdaq: REPH), a specialty pharmaceutical company that develops non-opioid drugs for the management of pain. He is also on the boards of a number of private companies, including Recro Pharma, LZ Therapeutics, and Echo360. He is Chairman of the Board of Trustees of the Young Scholars School. Mr. Weisman holds a BA from the University of Pennsylvania and a JD from the University Michigan Law School.
Dr. John William Poduska
Dr. John William Poduskahas been an external member of the board of ReWalk since September 2014. Dr. Poduska is currently a Director of EXA Corporation (NASDAQ: EXA), where he is Chairman of the Compensation Committee and a member of the Nominations and Governance Committee. He is also a director of the boards of a number of private companies. Dr. Poduska was also a director of Novell, Inc. until 2011 and of Anadarko Petroleum Corporation and Safeguard Scientifics, Inc. until 2009. Poduska was CEO of Advanced Visual Systems Inc., a provider of visualization software, from January 1992 to December 2001. From December 1989 to December 1991, Dr. Poduska President and Chief Executive Officer of Stardent Computer Inc., a computer manufacturer. From December 1985 to December 1989, Dr. Poduska Chairman and Chief Executive Officer of Stellar Computer Inc., a computer manufacturer he founded with the predecessor of Stardent Computer Inc. Prior to founding Stellar Computer, Inc., Dr. Poduska Apollo Computer Inc. and Prime Computer Inc. founded. Dr. Poduska has a Sc.D. from MIT and an honorary degree in Human Letters from Lowell University.
Yohanan Engelhardt has been on the board of ReWalk since 2018. Mr. Engelhardt was CFO and VP Finance of listed and private companies for 28 years, including 18 years at ViryaNet, a provider of software solutions for mobile workforce management. While at ViryaNet, he led all financial operations, M&A activities, private placements, the company’s initial public offering and the sale of the company to a large private equity firm in 2014. Since 2015, he has provided CFO services to early stage technology and medical device companies Available, as well as accounting services for an accounting firm.
Mr. Engelhardt holds a BA in Accounting and Economics from the Hebrew University of Jerusalem and CPA certifications in the US and Israel. He is a member of the American Institute of CPAs and the Institute of CPAs in Israel.
Randel E. Richner , BSN, MPH began serving on the ReWalk Board as of Nov. 1, 2020. She has over 30 years of experience in health care policy, reimbursement, economics. She has been active in public policy serving as the first industry representative on the Executive Committee of the Medicare Coverage Advisory Committee and currently serves on the Executive Dean’s Advisory Board at the University of Michigan’s School of Public Health. She founded The Neocure Group which provided health economics and reimbursement strategic services to the healthcare industry. Previously she established the global reimbursement functions for Boston Scientific. She holds a Master’s Degree in Public Health and Bachelors in Nursing from the University of Michigan.
Joseph Turk has served on the ReWalk Board since April 2022. Mr. Turk has been an Executive Vice President of Fresenius Medical Care North America since 2019, during which he has served as the President of its Renal Therapies group since July 2021 and as the President of its Home and Critical Care Therapies group from February 2019 until July 2021. He held a number of leadership roles, most recently President, at NxStage Medical, Inc. between 2000 to 2019. Prior to NxStage, Mr. Turk also spent time at Boston Scientific and McKinsey and Company. Mr. Turk holds a B.A. from Wabash College and an M.B.A from the Kellogg Graduate School of Management at Northwestern University.